Piramal Pharma (NSE:PPLPHARMA) Short Interest


NSE:PPLPHARMA Piramal Pharma Ltd NSE:PPLPHARMA
53 GF Score
Price ₹167.69
GF Value ₹175.28
Valuation Fairly Valued
! 3 Warning Signs
View Full Analysis

What is Piramal Pharma Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

NSE:PPLPHARMA vs ZTS, UTHR: Short Interest Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Piramal Pharma's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Piramal Pharma Short Interest vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Piramal Pharma's Short Interest distribution charts can be found below:

* The bar in red indicates where Piramal Pharma's Short Interest falls into.


NSE:PPLPHARMA
53GF Score
Piramal Pharma Ltd NSE:PPLPHARMA
Short Interest is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Piramal Pharma (NSE:PPLPHARMA) Overvalued in 2026?

Based on GuruFocus' analysis, Piramal Pharma stock appears to be undervalued. The current stock price of ₹167.69 is trading 4.3% below its estimated GF Value™ of ₹175.28. GuruFocus considers Piramal Pharma to be Fairly Valued.

Key valuation signals for NSE:PPLPHARMA:

  • Short Interest:
  • GF Value™: ₹175.28 vs. price of ₹167.69 (4.3% below fair value)
  • GF Score™: 53/100 with 3 warning signs

No single metric tells the full story. See the NSE:PPLPHARMA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Piramal Pharma Business Description

Other Exchanges 543635:India
Address Kamani Junction, LBS Marg, Ground Floor, Piramal Ananta, Agastya Corporate Park, Opposite Fire Brigade, Kurla (West), Mumbai, MH, IND, 400070
Piramal Pharma Ltd is a pharmaceutical company, providing end-to-end pharma services to customers and a portfolio of differentiated pharma products across a domestic and international distribution network. It operates under three business verticals; an integrated contract development and manufacturing (CDMO) business providing Active pharmaceutical ingredients (APIs), Finished dosage forms (FDFs), biologics, and vaccines among other products; the other two business verticals include a complex hospital generics business, and an India consumer healthcare business, selling over-the-counter products in India. Geographically, the company generates maximum revenue from North America and the rest from Europe, India, Japan, and other markets.
53GF Score

Get the complete analysis for NSE:PPLPHARMA

Short Interest is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹167.69
Price
₹175.28
GF Value